» Articles » PMID: 34861153

Trends in Leading Causes of Hospitalisation of Adults with Diabetes in England from 2003 to 2018: an Epidemiological Analysis of Linked Primary Care Records

Overview
Specialty Endocrinology
Date 2021 Dec 3
PMID 34861153
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes leads to a wide range of established vascular and metabolic complications that has resulted in the implementation of diverse prevention programmes across high-income countries. Diabetes has also been associated with an increased risk of a broader set of conditions including cancers, liver disease, and common infections. We aimed to examine the trends in a broad set of cause-specific hospitalisations in individuals with diabetes in England from 2003 to 2018.

Methods: In this epidemiological analysis, we identified 309 874 individuals 18 years or older with diabetes (type 1 or 2) in England from the Clinical Practice Research Datalink linked to Hospital Episode Statistics inpatient data from 2003 to 2018. We generated a mixed prevalent and incident diabetes study population through serial cross sections and follow-up over time. We used a discretised Poisson regression model to estimate annual cause-specific hospitalisation rates in men and women with diabetes across 17 cause groupings. We generated a 1:1 age-matched and sex-matched population of individuals without diabetes to compare cause-specific hospitalisation rates in those with and without diabetes.

Findings: Hospitalisation rates were higher for all causes in persons with diabetes than in those without diabetes throughout the study period. Diabetes itself and ischaemic heart disease were the leading causes of excess (defined as absolute difference in the rate in the populations with and without diabetes) hospitalisation in 2003. By 2018, non-infectious and non-cancerous respiratory conditions, non-diabetes-related cancers, and ischaemic heart disease were the most common causes of excess hospitalisation across men and women. Hospitalisation rates of people with diabetes declined and causes of hospitalisation changed. Almost all traditional diabetes complication groups (vascular diseases, amputations, and diabetes) decreased, while conditions non-specific to diabetes (cancers, infections, non-infectious and non-cancerous respiratory conditions) increased. These differing trends represented a change in the cause of hospitalisation, such that the traditional diabetes complications accounted for more than 50% of hospitalisation in 2003, but only approximately 30% in 2018. In contrast, the proportion of hospitalisations due to respiratory infections between the same time period increased from 3% to 10% in men and from 4% to 12% in women.

Interpretations: Changes in the composition of excess risk and hospitalisation burden in those with diabetes means that preventative and clinical measures should evolve to reflect the diverse set of causes that are driving persistent excess hospitalisation in those with diabetes.

Funding: Wellcome Trust.

Citing Articles

Dietary total antioxidant capacity and risk of prediabetes and diabetes mellitus: a systematic review and dose-response meta-analysis of 170,919 participants.

Li R, Shu L, Zhu Q, Lu D Front Nutr. 2025; 12:1541734.

PMID: 40070482 PMC: 11893433. DOI: 10.3389/fnut.2025.1541734.


Multiple long-term conditions as the next transition in the global diabetes epidemic.

Gregg E, Holman N, Sophiea M, Misra S, Pearson-Stuttard J, Valabhji J Commun Med (Lond). 2025; 5(1):42.

PMID: 39953177 PMC: 11828996. DOI: 10.1038/s43856-025-00742-9.


Contribution of infection to mortality in people with type 2 diabetes: a population-based cohort study using electronic records.

Carey I, Critchley J, Chaudhry U, DeWilde S, Limb E, Bowen L Lancet Reg Health Eur. 2024; 48:101147.

PMID: 39670170 PMC: 11634975. DOI: 10.1016/j.lanepe.2024.101147.


The burden of diabetes-associated multiple long-term conditions on years of life spent and lost.

Gregg E, Pratt A, Owens A, Barron E, Dunbar-Rees R, Slade E Nat Med. 2024; 30(10):2830-2837.

PMID: 39090411 PMC: 11485235. DOI: 10.1038/s41591-024-03123-2.


Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.

Gudemann L, Young K, Thomas N, Hopkins R, Challen R, Jones A Diabetologia. 2024; 67(9):1817-1827.

PMID: 38836934 PMC: 11410842. DOI: 10.1007/s00125-024-06190-9.


References
1.
Vamos E, Millett C, Parsons C, Aylin P, Majeed A, Bottle A . Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004-2009. Diabetes Care. 2012; 35(2):265-72. PMC: 3263914. DOI: 10.2337/dc11-1682. View

2.
Aylin P, Williams S, Bottle A, Jarman B . Counting hospital activity: spells or episodes?. BMJ. 2004; 329(7476):1207. PMC: 529361. DOI: 10.1136/bmj.329.7476.1207. View

3.
Harding J, Shaw J, Peeters A, Davidson S, Magliano D . Age-Specific Trends From 2000-2011 in All-Cause and Cause-Specific Mortality in Type 1 and Type 2 Diabetes: A Cohort Study of More Than One Million People. Diabetes Care. 2016; 39(6):1018-26. DOI: 10.2337/dc15-2308. View

4.
Smolina K, Wright F, Rayner M, Goldacre M . Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ. 2012; 344:d8059. PMC: 3266430. DOI: 10.1136/bmj.d8059. View

5.
Herrett E, Gallagher A, Bhaskaran K, Forbes H, Mathur R, van Staa T . Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015; 44(3):827-36. PMC: 4521131. DOI: 10.1093/ije/dyv098. View